Dr Alma Fulurija
Alma has a PhD in Immunology, and almost 20 years of experience in biotech companies and pharma in Switzerland and Australia. She has deep expertise in leading development and commercialisation of immunotherapies and vaccines, as well as in planning and leading clinical trials. Alma is currently Project Lead for the Australian Strep A Vaccine Initiative (ASAVI), which is taking a selected global Strep A vaccine candidate through clinical development.
Alma holds an adjunct senior lecturer position at University of Western Australia.